Carlo Palmieri

15PUBLICATIONS
90CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 12, 2025
UGT1A1 and Sacituzumab Govitecan Toxicity: A Systematic Review and Meta-Analysis.

Cinzia Dello Russo, Innocent Gerald Asiimwe, Sudeep Pushpakom

|Mar 06, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

R C Coombes, Sacha Howell, Simon R Lord

|Jun 05, 2024
Analysis of Breast Cancer Brain Metastases Reveals an Enrichment of Cyclin-Dependent Kinase 12 Structural Rearrangements in Human Epidermal Growth Factor Receptor 2-Positive Disease.

Talvinder Bhogal, Athina Giannoudis, Ethan Sokol

|Dec 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Maria Coakley, Guillermo Villacampa, Prithika Sritharan

|Aug 07, 2023
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

R C Coombes, Sacha Howell, Simon R Lord

|Jul 24, 2023
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

R C Coombes, Sacha Howell, Simon R Lord

Pageof 3

Frequent Collaborators

4 joint publications

Simak Ali

3 joint publications

Simon R Lord

3 joint publications

Matthew G Krebs

3 joint publications

Patrick Ward